热门资讯> 正文

Acurx Pharmaceuticals重新遵守纳斯达克上市规则

2025-09-03 19:42

纳比特(NA) 0
盛大科技(SDA) 0
Acurx Pharmaceuticals LLC Ordinary Shares(ACXP) 0

Acurx Pharmaceuticals (NASDAQ:ACXP) has regained compliance with Nasdaq’s minimum closing bid price and minimum stockholders' equity threshold requirements for continued listing on the exchange.
The company's common stock will remain listed and traded on the Nasdaq Stock Market.

More on Acurx Pharmaceuticals

Acurx Pharmaceuticals, Inc. (ACXP) Q2 2025 Earnings Call Transcript
Acurx signals ongoing cost controls and new trial funding avenues while advancing ibezapolstat clinical program
Acurx Pharmaceuticals files $50M mixed shelf offering
Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
Historical earnings data for Acurx Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。